[Comment on article "Enoxaparin dose associated with decreased risk of death in COVID-19"]

Rev Med Inst Mex Seguro Soc. 2022 May 2;60(3):247-248.
[Article in Spanish]

Abstract
in English, Spanish

In this letter to the editor, apropos of the article "Enoxaparin dose associated with decreased risk of death in COVID-19", it is discussed the role of the current thromboprophylactic strategies, as well as the potential role of heparins in the management of COVID-19.

En la presente carta al editor, a propósito del artículo “Dosis de enoxaparina asociada a disminución de riesgo de muerte en COVID-19”, se discute el papel de las estrategias de tromboprofilaxis y el potencial rol de las heparinas en relación con la COVID-19.

Keywords: Anticoagulants; Heparins; SARS-CoV-2; Venous Thromboembolism.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • COVID-19*
  • Enoxaparin* / therapeutic use
  • Humans

Substances

  • Anticoagulants
  • Enoxaparin